# Context outside the implementation record

Compiled 12 November 2026, Asia/Tashkent; checked against repository commit `788272762ecb62d655875e006d679fb04ea81828`.
Sources: the supplied `messages.html` group export, Imamatdin's conversation with the planner, and the initial prototype review. Export timestamps below are UTC+05:00. Chat reports were received by 11 November; their exact individual message times are unavailable here.
This records only additional context. Existing technical source findings and 1C archive inspection results remain in `STATE-2026-11-11.md` and `REUSE-MANIFEST.md`; product scope, builder rules and implementation handoffs are not repeated.

## Founder conversations and the reason for the work

- **10 November, 21:19–21:20 — group export:** Mashxuraxon supplied `allfinalpitchclinoraaiaward.pdf` and explicitly described it as better aligned with their current goals and containing the latest changes. That comment replies to the pitch attachment, not to a code archive.
- **Reported by 11 November — Imamatdin:** the founder's pitch included her father's death without knowing his diagnosis and connected the experience to bureaucracy and repetitive documentation. Imamatdin explicitly said he had not memorized the details. The medical circumstances and claimed causal connection are UNVERIFIED; this is his recollection of the pitch, not an established case history.
- **Reported by 11 November — Imamatdin:** the founders said customer-discovery interviews raised the objection that DMED would release the same functionality and overpower Clinora. The competitive objection came from their reported interviews; no interview transcripts were supplied to the planner.
- **Reported by 11 November — Imamatdin:** he asked whether they wanted to replace DMED; they answered no and said they did not want to wait. His own negative experience of DMED was personal experience, not a comparative product evaluation.
- **10 November — forwarded publicity:** a Startup Garage post dated 7 November described the team as working on pilots with two clinics and named Mashxuraxon and Azizaxon as residents. It did not establish that either pilot was already operating or paying.
- **By 11 November — pasted owner exchange:** Aziza replied “Ok” to Imamatdin's proposed work summary. When he asked about misunderstandings, she added the doctor voice-to-text requirement already captured in `DELIVERY-PLAN-002.md`. Her response did not enumerate or approve individual implementation choices.

## Imamatdin's priorities and rejected approaches

- **10 November, 21:21–21:23 — group export:** Mashxuraxon offered to connect her account. Imamatdin declined because his agents were already connected to his account and reconnecting would consume time. He proposed a public repository so the founders could inspect the code; Mashxuraxon agreed. This exchange did not settle intellectual-property ownership or licensing terms.
- **By 11 November — direct instruction:** Imamatdin rejected the earlier limited plan as work he, the planner and Claude could finish in “12 hours at most.” He asked for more substantial engineering that could support fundraising and continued product use. The 12-hour statement was his criticism of that proposed scope, not an agreed estimate for the whole product.
- **By 11 November — direct instruction:** he expressed dissatisfaction with the existing developers' pace and wanted to ship, then iterate on customer feedback. No independent assessment of those developers' competence or working conditions was made.
- **By 11 November — change of instruction:** he initially suggested waiting for the founder's evening workflow delivery. He subsequently asked the planner to proceed from available evidence while he gathered more details. Waiting for a complete workflow was therefore not his final direction.
- **By 11 November — commercial arrangement reported by Imamatdin:** he asked the founders for a $20 Claude subscription for the sprint. He said compensation for his time could be discussed if investment arrived or they wanted continued work. Payment of the subscription, a continuing fee and an equity agreement were not confirmed in this conversation.
- **By 11 November — personal workflow account:** Imamatdin described public-clinic checkups in Nukus where staff asked whether anything was bothering him, performed no examination in his account, and recorded him as healthy. He also alleged invented entries. This was his personal report, not a supplied consultation recording or a verified description of the participating clinics.

## Prototype identity and additional source context

- **10 November, 21:11 — group export:** Aziza forwarded Mashxuraxon's earlier link to [clinoraa.base44.app](https://clinoraa.base44.app). The planner has no independently verified mapping from that deployed app to either supplied GitHub repository or source archive, and no completed Base44 runtime/security audit.
- **11 November — supplied screenshot:** the visible browser address is `https://clinora-ai-doc-assist.lovable.app/app#`. The screenshot accompanying Imamatdin's UI complaints is of the Lovable app, not Base44. Attribution of each reported defect to both deployments is UNVERIFIED.
- **10 November, 21:13 — group export:** Mashxuraxon forwarded [mvpclinora2.pages.dev](https://mvpclinora2.pages.dev), followed by “Gofurov” and “klinikasi.” The forwarded link itself carried a 7 August 2025 timestamp. These messages do not establish the deployment's current operational status or which archive produced it.
- **10 November, 22:05–22:06 — group export:** `БАЗА.zip` was forwarded from “Gʻofurov klinikasi.” Mashxuraxon described it as containing the registration structure and said she would find laboratory, cashier and administrator materials the next day. This records the sender's intended context; the actual archive-content findings are already in `STATE-2026-11-11.md`.
- **10 November — exported media gap:** the forwarded Startup Garage video is listed as 59 seconds / 13.6 MB, with an export message saying the file exceeded the selected size limit. The video itself was not included in that export.
- **10 November, 21:39 — unassessed reference:** Mashxuraxon shared [a YouTube video](https://youtu.be/5pzVd4ip_cg?si=wTj7FzGN4pIaguLa). No consultation-workflow findings were established from that video in the planner's review.

## Remaining interpretation limits from the conversations

- **By 11 November:** Imamatdin repeatedly said he understood the general vision but still needed to ask exactly where the founders wanted automation. “More agentic” was their reported wording; it was not a supplied list of autonomous actions or permission to execute clinical decisions.
- **By 11 November:** his initial commitment to the founders was to examine their process and existing product, then explain how he could help. His enthusiasm for the founders and fundraising goal did not include a guarantee of investment or a promise of universal specialty accuracy.
